The best place to get tirzepatide depends on three factors: whether your insurance covers Zepbound or Mounjaro, your out-of-pocket budget, and your tolerance for risk with compounded versions. LillyDirect, traditional pharmacies, and major telehealth platforms each offer legitimate access to brand-name tirzepatide, while compounded options have become more limited since the FDA shortage exemption ended in late 2024.
What Is Tirzepatide and Why Sourcing Matters
Tirzepatide is the active ingredient in two FDA-approved injectable medications made by Eli Lilly: Mounjaro for type 2 diabetes and Zepbound for chronic weight management in adults with obesity or overweight plus a weight-related condition. It is a once-weekly dual GIP/GLP-1 receptor agonist that lowers blood glucose, slows gastric emptying, and reduces appetite. Because the medication is in such high demand and has a high price tag, sourcing has become as important as the prescription itself. Where you fill a tirzepatide Rx affects cost, formulation, dosing flexibility, and even whether the product is FDA-approved.
LillyDirect: Manufacturer Direct Self-Pay
LillyDirect is Eli Lilly’s direct-to-patient pharmacy launched to make Zepbound more affordable for self-pay patients. Single-dose vials are sold at lower prices than the prefilled auto-injector pens. As of 2025, published self-pay prices include roughly $349 per month for 2.5 mg vials, $499 for 5 mg vials, and tiered pricing for higher doses. You still need a valid Zepbound prescription from a US-licensed clinician. The vials require you to draw up the dose with a syringe, so the program is best suited for patients comfortable with that step. LillyDirect ships through Gifthealth and other partner pharmacies.
Traditional Pharmacy with Insurance
If you have commercial insurance that covers Zepbound or Mounjaro, a traditional retail or mail-order pharmacy is usually the cheapest path. Copays vary widely, from $25 to over $500 per month depending on your formulary tier and prior-authorization rules. The Zepbound and Mounjaro savings cards from Eli Lilly can lower commercial copays to as low as $25 per month for eligible patients, though Medicare and Medicaid enrollees are excluded by federal rules. Always check your plan’s prior-authorization criteria before assuming coverage, because many plans require a documented BMI threshold or a failed trial of other therapies.
Telehealth Platforms
Telehealth has become one of the most popular ways to start tirzepatide because it bundles the prescriber visit, lab review, and pharmacy fulfillment into one monthly subscription. Each platform varies in whether it dispenses brand-name or compounded tirzepatide:
| Platform | Typical Monthly Cost | Formulation |
|---|---|---|
| Hers / Hims | $199-$499 | Compounded (where legal) or brand |
| Ro | $229-$499 | Compounded or brand Zepbound |
| Mochi Health | $79 visit + Rx cost | Brand Zepbound or Mounjaro |
| Sequence (by Weight Watchers) | $99 + Rx | Brand only |
| LillyDirect Telehealth | Variable | Brand Zepbound only |
Telehealth is convenient but you still need a real clinician evaluation. Avoid any service that ships GLP-1 medications without a video or written health questionnaire reviewed by a US-licensed prescriber.
Compounded Tirzepatide: Legal Status in 2025
From 2022 to late 2024, tirzepatide was on the FDA drug shortage list, which allowed compounding pharmacies to produce essentially-a-copy versions for patients. In December 2024 the FDA declared the shortage resolved, and large-scale 503B outsourcing facilities had to stop producing compounded tirzepatide by early 2025. According to the FDA’s compounding policy update, state-licensed 503A pharmacies may still produce patient-specific compounded versions when a clinician documents a clinical need, but this is much narrower than the previous era. Quality, sterility, and dose accuracy can vary between compounders, and the FDA does not review compounded products for safety or efficacy.
What to Look for in a Reputable Source
- The pharmacy is licensed in your state (verifiable on your state board of pharmacy website).
- A US-licensed clinician reviews your medical history before prescribing.
- The product is shipped cold-chain and arrives sealed with clear labeling and a National Drug Code (NDC) for brand-name versions.
- You receive a sharps container, alcohol pads, and written dosing instructions.
- Customer service can answer questions about side effects, missed doses, and refills.
Cost Comparison Snapshot
| Source | Typical Monthly Cost | Formulation |
|---|---|---|
| Insurance + retail pharmacy | $25-$500 copay | Brand Zepbound / Mounjaro |
| LillyDirect vials | $349-$649 | Brand Zepbound |
| Telehealth (brand) | $499-$1,000+ | Brand Zepbound / Mounjaro |
| Telehealth (compounded) | $199-$499 | Compounded tirzepatide |
| Cash retail (no insurance) | ~$1,060 | Brand Zepbound pens |
Safety, Side Effects, and Clinical Oversight
Tirzepatide can cause nausea, vomiting, diarrhea, constipation, and rarely pancreatitis or gallbladder disease. The FDA prescribing label for Zepbound carries a boxed warning about thyroid C-cell tumors observed in rodents. Whether you fill at LillyDirect or a telehealth compounder, you need a clinician who can dose-escalate slowly, manage GI side effects, and order baseline labs (thyroid, kidney function, lipase if symptomatic). For background on weight-related metabolic conditions, see the Prediabetes Centers treatment hub and the prediabetes 101 overview.
The Bottom Line
If you have insurance coverage, a traditional pharmacy is usually cheapest. Without insurance, LillyDirect single-dose vials at $349-$499 per month are the most affordable brand-name option. Telehealth platforms add convenience and a built-in prescriber but cost more. Compounded tirzepatide is now harder to access legally and quality is variable, so use it only when prescribed by a clinician who specifies a state-licensed 503A pharmacy.
Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider with any questions about a medical condition or medication.
